Bristol-Myers Squibb
BMY
BMY
2,346 hedge funds and large institutions have $80.8B invested in Bristol-Myers Squibb in 2023 Q4 according to their latest regulatory filings, with 249 funds opening new positions, 666 increasing their positions, 1,206 reducing their positions, and 238 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
2,346
Holders Change
-26
Holders Change %
-1.1%
% of All Funds
34.39%
Holding in Top 10
24
Holding in Top 10 Change
-18
Holding in Top 10 Change %
-42.86%
% of All Funds
0.35%
New
249
Increased
666
Reduced
1,206
Closed
238
Calls
$1.7B
Puts
$1.2B
Net Calls
+$495M
Net Calls Change
-$10.8M
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$1.14B |
| 2 |
VanEck Associates
New York
|
+$184M |
| 3 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$165M |
| 4 |
Primecap Management
Pasadena,
California
|
+$154M |
| 5 |
Voloridge Investment Management
Jupiter,
Florida
|
+$137M |
